Find out about a new software solution, developed and validated in a two-year collaborative project involving Intellegens, CPI, and leading pharma/biotech partners, that applies the power of machine learning to enable development of oligonucleotide manufacturing.
With high specificity and the ability to treat a broad range of diseases, oligonucleotides are poised for a significant impact as therapeutics. But there are currently few products on the market and manufacturing knowledge and experience is limited outside of a small number of specialist companies. A new machine learning software solution can help oligonucleotide researchers to meet the challenge of bringing oligonucleotide therapies to market.
In this webinar, we introduce Alchemite™ for Oligonucleotide Manufacturing, developed through a two year collaboration between Intellegens, the Centre for Process Innovation (CPI), and pharmaceutical and biotech partners. You see how Alchemite™ is helping to optimize process parameters, generate new insights, and reduce critical impurities in the development of new oligonucleotide processes. We share experience of applying Alchemite™ machine learning in real oligos projects at CPI. And we will provide a live demo of the system and answer your questions. Learn how machine learning can enable routine process optimization with less input from senior experts, provides researchers with valuable guidance, and capture vital organizational knowledge.
Original broadcast date: 23 Sep, 2025
